Inventor · disambiguated record
Gregory I. Frost
Also filed as: FROST GREGORY · FROST GREGORY I · FROST GREGORY IAN
53 granted patents·35 pending applications·2,530 citations·filing 1995–2025
99Inventor score
Top patents by PatentIndex Score
88 records- 0199US7871607B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2005·Granted Jan 18, 2011·128 cites·32 claims
- 0299US7846431B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2010·Granted Dec 7, 2010·89 cites·18 claims
- 0399US7829081B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2010·Granted Nov 9, 2010·92 cites·21 claims
- 0499US7767429B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2004·Granted Aug 3, 2010·250 cites·52 claims
- 0598US10016491B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2015·Granted Jul 10, 2018·28 cites·28 claims
- 0698US8772246B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofBOOKBINDER LOUIS H·Filed 2012·Granted Jul 8, 2014·81 cites·24 claims
- 0798US8580252B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesBOOKBINDER LOUIS H·Filed 2012·Granted Nov 12, 2013·91 cites·34 claims
- 0898US8431380B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofBOOKBINDER LOUIS·Filed 2009·Granted Apr 30, 2013·88 cites·33 claims
- 0998US8431124B2Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)BOOKBINDER LOUIS H·Filed 2009·Granted Apr 30, 2013·71 cites·21 claims
- 1098US8257699B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesBOOKBINDER LOUIS H·Filed 2011·Granted Sep 4, 2012·80 cites·23 claims
- 1198US8202517B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofBOOKBINDER LOUIS H·Filed 2009·Granted Jun 19, 2012·91 cites·28 claims
- 1298US8105586B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesBOOKBINDER LOUIS H·Filed 2010·Granted Jan 31, 2012·90 cites·26 claims
- 1397US10588983B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2018·Granted Mar 17, 2020·27 cites·10 claims
- 1497US9677061B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofBOOKBINDER LOUIS H·Filed 2010·Granted Jun 13, 2017·32 cites·30 claims
- 1597US9211315B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2014·Granted Dec 15, 2015·36 cites·29 claims
- 1697US8765685B2Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)BOOKBINDER LOUIS·Filed 2012·Granted Jul 1, 2014·63 cites·23 claims
- 1797US7781397B2Human plasma hyaluronidaseUNIV CALIFORNIA·Filed 2006·Granted Aug 24, 2010·66 cites·29 claims
- 1896US10286044B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2017·Granted May 14, 2019·14 cites·22 claims
- 1996US9677062B2Hyaluronidase and factor VIII compositionsBOOKBINDER LOUIS H·Filed 2011·Granted Jun 13, 2017·22 cites·25 claims
- 2096US7718428B2Myeloid colony stimulating factor and uses thereofHALOZYME INC·Filed 2006·Granted May 18, 2010·27 cites·3 claims
- 2196US7544499B2Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2003·Granted Jun 9, 2009·49 cites·17 claims
- 2296US7148201B2Use of human plasma hyaluronidase in cancer treatmentUNIV CALIFORNIA·Filed 2001·Granted Dec 12, 2006·76 cites·18 claims
- 2396US7105330B2Human plasma hyaluronidaseUNIV CALIFORNIA·Filed 2003·Granted Sep 12, 2006·84 cites·74 claims
- 2495US10328130B2Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditionsFROST GREGORY I·Filed 2012·Granted Jun 25, 2019·27 cites·31 claims
- 2595US8450470B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofBOOKBINDER LOUIS H·Filed 2009·Granted May 28, 2013·87 cites·30 claims
- 2695US8318154B2Super fast-acting insulin compositionsFROST GREGORY I·Filed 2009·Granted Nov 27, 2012·82 cites·81 claims
- 2794US8568713B2Super fast-acting insulin compositionsFROST GREGORY I·Filed 2012·Granted Oct 29, 2013·41 cites·42 claims
- 2894US6193963B1Method of treating tumor-bearing patients with human plasma hyaluronidaseUNIV CALIFORNIA·Filed 1997·Granted Feb 27, 2001·94 cites·3 claims
- 2993US11325948B2Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPLEXUMA BIOTECH CORP·Filed 2020·Granted May 10, 2022·6 cites·27 claims
- 3093US9562223B2Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP)HALOZYME INC·Filed 2014·Granted Feb 7, 2017·10 cites·24 claims
- 3193US9284543B2Neutral active soluble truncated PH20 polypeptides and uses thereofWEI GE·Filed 2012·Granted Mar 15, 2016·39 cites·22 claims
- 3292US12258574B2Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2023·Granted Mar 25, 2025·1 cites·26 claims
- 3392US11723959B2Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptideHALOZYME INC·Filed 2020·Granted Aug 15, 2023·2 cites·13 claims
- 3492US10596274B2Methods and compositions for transducing lymphocytes and regulated expansion thereofEXUMA BIOTECH CORP·Filed 2017·Granted Mar 24, 2020·10 cites·24 claims
- 3592US8927249B2Extended soluble PH20 polypeptides and uses thereofWEI GE·Filed 2009·Granted Jan 6, 2015·26 cites·37 claims
- 3691US10898551B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2019·Granted Jan 26, 2021·2 cites·41 claims
- 3790US8815558B2Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereofFROST GREGORY I·Filed 2009·Granted Aug 26, 2014·9 cites·14 claims
- 3890US6682904B1Specific inhibitors of hyaluronidase 2, and methods of identifying and using sameDELIATROPH PHARMACEUTICALS INC·Filed 2002·Granted Jan 27, 2004·43 cites·28 claims
- 3989US5827721ABH55 hyaluronidaseUNIV CALIFORNIA·Filed 1997·Granted Oct 27, 1998·93 cites·8 claims
- 4089US5747027ABH55 hyaluronidaseUNIV CALIFORNIA·Filed 1995·Granted May 5, 1998·101 cites·5 claims
- 4189US2025222078A1Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditionsHALOZYME INC·Filed 2024·Application pending·0 cites
- 4289US2023321203A1SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOFHALOZYME INC·Filed 2023·Application pending·0 cites
- 4388US11111505B2Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2017·Granted Sep 7, 2021·3 cites·21 claims
- 4487US12325728B2Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of CD79A and CD79BEXUMA BIOTECH CORP·Filed 2022·Granted Jun 10, 2025·1 cites·26 claims
- 4587US6123938AHuman urinary hyaluronidaseUNIV CALIFORNIA·Filed 1997·Granted Sep 26, 2000·72 cites·9 claims
- 4685US9034323B2Method for control of post-prandial glucoseFROST GREGORY I·Filed 2013·Granted May 19, 2015·9 cites·52 claims
- 4785US6103525AHybridoma cell lines producing monoclonal antibodies that bind to human plasma hyaluronidaseUNIV CALIFORNIA·Filed 1996·Granted Aug 15, 2000·52 cites·2 claims
- 4884US10265410B2Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effectsHALOZYME INC·Filed 2016·Granted Apr 23, 2019·4 cites·35 claims
- 4984US9878046B2Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effectsSHEPARD HAROLD MICHAEL·Filed 2011·Granted Jan 30, 2018·11 cites·68 claims
- 5083US9333244B2Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasiaLI XIAOMING·Filed 2013·Granted May 10, 2016·9 cites·72 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →